Last reviewed · How we verify

NCT02554110

Peripheral Nerve Stimulation to Reduce Hypoxic Events

Completed NA Last updated 15 November 2018
What this trial tests

NA trial testing Stimulator active device in Apnea in 80 participants. Completed in 19 January 2017.

Timeline
12 October 2015
Primary endpoint
19 January 2017
19 January 2017

Quick facts

Lead sponsorMayo Clinic
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment80
Start date12 October 2015
Primary completion19 January 2017
Estimated completion19 January 2017
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with Apnea or Hypoventilation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is designed to determine if using peripheral nerve stimulation in conjunction with pulse oximetry as an adjunct to traditional monitoring in the PACU reduces the frequency and severity of sedation related apnea and hypoxic events.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Peripheral electrical stimulation reduces postoperative hypoxemia in patients at risk for obstructive sleep apnea: a randomized-controlled trial.
    Smith HM, Kilger J, Burkle CM, Schroeder DR, et al · · 2019 · cited 1× · PMID 31338807 · DOI 10.1007/s12630-019-01451-3

Verify or expand the search:

Other recruiting trials for Apnea

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02554110.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing